| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |